Azactam and Ibu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azactam (aztreonam) and Ibu (ibuprofen). Common drug interactions include vomiting among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Azactam and Ibu. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Azactam?

Azactam has active ingredients of aztreonam. eHealthMe is studying from 1,044 Azactam users. Check the latest studies of Azactam.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.

On Aug, 10, 2026

18 people who take Azactam and Ibu together, and have interactions are studied.

What are the common drug interactions of Azactam and Ibu, by gender? *:

female:

Vomiting
Aspartate aminotransferase increased
Deafness transitory (deafness temporary)
Death
Grand mal convulsion (a type of generalized seizure that affects the entire brain)
Hepatitis (inflammation of the liver)
Hidradenitis (chronic disease of a type of sweat gland)
International normalised ratio increased
Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
Tachypnoea (a condition of rapid breathing over 20 per minute)

male:

Pyrexia (fever)
Alopecia (absence of hair from areas of the body)
Chest pain
Conjunctivitis (pink eye)
Death
Decreased appetite
Depressed level of consciousness
Depression
Ear infection
Failure to thrive (inadequate weight gain and physical growth in children)

What are the common drug interactions of Azactam and Ibu, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

International normalised ratio increased
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Aspartate aminotransferase increased
Hepatitis (inflammation of the liver)

10-19:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
Nausea (feeling of having an urge to vomit)
Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
Pancreatitis acute (sudden inflammation of pancreas)
Vomiting
Hidradenitis (chronic disease of a type of sweat gland)
Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)

20-29:

Hepatobiliary disease (diseases affect the liver and/or biliary tract)

30-39:

Deafness transitory (deafness temporary)

40-49:

Renal failure (kidney dysfunction)
Dyspnoea (difficult or laboured respiration)
Death
Alopecia (absence of hair from areas of the body)
Arthralgia (joint pain)
Asthenia (weakness)
Asthma
Attention deficit/hyperactivity disorder
Axonal neuropathy (dysfunction of axon nerves)
Blood immunoglobulin e increased

50-59:

Renal failure (kidney dysfunction)
Abscess limb (limb infection)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Sepsis (a severe blood infection that can lead to organ failure and death)
Chronic kidney disease
Post-traumatic stress disorder

60+:

Dysphagia (a condition in which swallowing is difficult or painful)
Grand mal convulsion (a type of generalized seizure that affects the entire brain)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 33.33%
Asthma: 3 people, 16.67%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 3 people, 16.67%
Swelling: 3 people, 16.67%
High Blood Cholesterol: 3 people, 16.67%
Infection: 3 people, 16.67%
White Blood Cell Disorder: 2 people, 11.11%
Fluid Overload (too much fluid in the blood): 2 people, 11.11%
Gastrointestinal Toxicity (damage to digestive tract by any substance): 2 people, 11.11%
Fungal Infection: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Azactam and Ibu?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously